Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Price

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|December 3, 2019
What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?Sarah B Joseph, Mattia Trunfio, Laura P Kincer, et al.
AIDS (London, England)|July 16, 2014
Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activationViktor Dahl, Julia Peterson, Dietmar Fuchs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapyAylin Yilmaz, Richard W Price, Serena Spudich, et al.
Frontiers in Immunology|March 12, 2025
Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infectionPhillip Chan, Xiang Li, Fangyong Li, et al.
The Lancet. Infectious Diseases|September 26, 2009
Progressive multifocal leukoencephalopathy in HIV-1 infectionPaola Cinque, Igor J Koralnik, Simonetta Gerevini, et al.
Neuroepidemiology|October 26, 2013
Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and powerAna-Claire L Meyer, W John Boscardin, Judith K Kwasa, et al.
AIDS (London, England)|August 17, 2005
Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapyJutta K Neuenburg, Scott Furlan, Peter Bacchetti, et al.
The Journal of Infectious Diseases|January 15, 2008
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapyArvid Edén, Richard W Price, Serena Spudich, et al.
AIDS (London, England)|August 28, 2014
Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infectionFelicia C Chow, Peter Bacchetti, Anthony S Kim, et al.
The Journal of Infectious Diseases|May 12, 2007
Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complexMagnus Gisslen, Lars Hagberg, Bruce J Brew, et al.
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|December 3, 2019
What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?Sarah B Joseph, Mattia Trunfio, Laura P Kincer, et al.
AIDS (London, England)|July 16, 2014
Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activationViktor Dahl, Julia Peterson, Dietmar Fuchs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapyAylin Yilmaz, Richard W Price, Serena Spudich, et al.
Frontiers in Immunology|March 12, 2025
Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infectionPhillip Chan, Xiang Li, Fangyong Li, et al.
The Lancet. Infectious Diseases|September 26, 2009
Progressive multifocal leukoencephalopathy in HIV-1 infectionPaola Cinque, Igor J Koralnik, Simonetta Gerevini, et al.
Neuroepidemiology|October 26, 2013
Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and powerAna-Claire L Meyer, W John Boscardin, Judith K Kwasa, et al.
AIDS (London, England)|August 17, 2005
Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapyJutta K Neuenburg, Scott Furlan, Peter Bacchetti, et al.
The Journal of Infectious Diseases|January 15, 2008
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapyArvid Edén, Richard W Price, Serena Spudich, et al.
AIDS (London, England)|August 28, 2014
Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infectionFelicia C Chow, Peter Bacchetti, Anthony S Kim, et al.
The Journal of Infectious Diseases|May 12, 2007
Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complexMagnus Gisslen, Lars Hagberg, Bruce J Brew, et al.
Pageof 15